BMYB34:BVMF
Bristol-Myers Squibb Company BDR
R$328,68
arrow_downward
-2,47%(-8,32) 1D
7 ສ.ຫ., 16 ໂມງ 56 ນາທີ 00 ວິນາທີ GMT-3 · BRL
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BMYB34...
Open
R$327,70
High
R$328,68
Low
R$326,50
Mkt. cap
໑໓໒,໒໐ ຕື້
Avg. vol.
໐,໐໐
Volume
໑໑,໐໐
52-wk high
R$337,00
52-wk low
R$223,16
Shares outstanding
໒,໐໔ ຕື້
No. of employees
໓໒ ພັນ
Open
R$327,70
High
R$328,68
Low
R$326,50
Mkt. cap
໑໓໒,໒໐ ຕື້
Avg. vol.
໐,໐໐
Volume
໑໑,໐໐
52-wk high
R$337,00
52-wk low
R$223,16
Shares outstanding
໒,໐໔ ຕື້
No. of employees
໓໒ ພັນ
News stories
From sources across the web
Profile
Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. The company's primary products are apixaban for people with atrial fibrillation; nivolumab, used to treat certain types of cancer; lenalidomide, used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes; abatacept, used to treat autoimmune diseases such as rheumatoid arthritis; pomalidomide, an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related Kaposi sarcoma; ipilimumab, to treat cancer; and luspatercept for the treatment of anemia in beta thalassemia and myelodysplastic syndromes. In 2025, 69% of the company's revenues came from the United States.
The company is ranked 94th on the Fortune 500 and 173rd on the Forbes Global 2000. Wikipedia
About Bristol-Myers Squibb Company BDR
CEOChris Boerner
Employees32,5 ພັນ
Founded1887
Headquartersນິວຢອກ, ລັດນີວຢອກ, ສະຫະລັດ
SectorPharmaceutical industry
Websitebms.com
AI content may include mistakes. Learn more